Evidence map›Paper›PMID 38656011›Full record

ArticleRevista da Associacao Medica Brasileira (1992)2024

Are depression and poor sleep quality a major problem in Turkish Women receiving chemotherapy for breast cancer?

Mahmut Buyuksimsek, Ahmet Gulmez, Okan Pirinci, Mert Tohumcuoglu, Mehmet Mutlu Kidi

Open access · diamondAbstract read
In one paragraph

Article in Revista da Associacao Medica Brasileira (1992), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mahmut BuyuksimsekUniversity of Health Sciences, Adana Health Practice and Research Center, Department of Medical Oncology - Adana, Turkey.ORCID http://orcid.org/0000-0001-6356-9059
Ahmet GulmezUniversity of Health Sciences, Adana Health Practice and Research Center, Department of Medical Oncology - Adana, Turkey.ORCID http://orcid.org/0000-0002-3353-344X
Okan PirinciUniversity of Health Sciences, Adana Health Practice and Research Center, Department of Internal Medicine - Adana, Turkey.ORCID http://orcid.org/0000-0001-9699-1256
Mert TohumcuogluUniversity of Health Sciences, Adana Health Practice and Research Center, Department of Medical Oncology - Adana, Turkey.ORCID http://orcid.org/0000-0003-3653-4429
Mehmet Mutlu KidiCukurova University, Department of Medical Oncology - Adana, Turkey.ORCID http://orcid.org/0000-0002-4750-720X
Sağlık Bilimleri Üniversitesi · TRCukurova University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to evaluate depression and sleep quality in Turkish women receiving neoadjuvant or adjuvant chemotherapy for breast cancer and investigate their relationship.

methodsThis cross-sectional, descriptive, and analytical study included 183 patients who received chemotherapy for non-metastatic breast cancer. Data were collected using the Beck Depression Inventory-II, the Pittsburgh Sleep Quality Index, and a disease-related/sociodemographic information form.

resultsThe mean age of the participants was 50.2 years, and 50.3% were in menopause. The mean Beck Depression Inventory-II score was 19.64±10.4. Mild depression was detected in 25.7% (n=47) of the women, and moderate or severe depression in 55.2% (n=101). The mean global score of sleep quality was found to be 8.28±2.62, and the majority of the participants (79.7%, n=146) had poor sleep quality. There was a positive correlation (p<0.001, r=0.43) between depression and sleep quality scores. While a negative correlation was found between depression scores and age (p<0.001, r=0.26), the surgical procedure performed did not significantly affect depression scores (p=0.705). Additionally, depression scores were positively correlated with sleep duration (p<0.001, r=0.42) and sleep latency (p=0.01, r=0.48).

conclusionVery high rates of depression and poor sleep quality were detected among Turkish women receiving neoadjuvant or adjuvant chemotherapy for breast cancer. The entire healthcare team involved in the treatment process should take this relationship into consideration and use the necessary preventive and therapeutic methods.

Indexed as

Breast NeoplasmsDepressionSleep QualityAdultAgedChemotherapy, AdjuvantCross-Sectional StudiesFemaleHumansMiddle AgedNeoadjuvant TherapyPsychiatric Status Rating ScalesSeverity of Illness IndexSleep Wake DisordersSocioeconomic FactorsSurveys and Questionnaires

Identifiers

PMID38656011
PMCPMC11042824
OpenAlexW4395466125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.